Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 14, Pages 8025
Publisher
MDPI AG
Online
2022-07-21
DOI
10.3390/ijms23148025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired resistance to third-generation EGFR tyrosine kinase inhibitors in patients with de novo EGFRT790M-mutant non–small cell lung cancer
- (2021) Ha-Ram Park et al. Journal of Thoracic Oncology
- Targeting MET in EGFR resistance in non-small-cell lung cancer—ready for daily practice?
- (2020) Sabine Schmid et al. LANCET ONCOLOGY
- LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
- (2020) Suyeon Kim et al. Autophagy
- A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
- (2020) Adileh Ayati et al. BIOORGANIC CHEMISTRY
- Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway
- (2020) Yuhong Lu et al. CANCER RESEARCH
- Ligand decorated chitosan as an advanced nanocarrier for targeted delivery: a critical review
- (2019) Maimoona Qindeel et al. Nanomedicine
- EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
- (2019) Xuan Zhu et al. Frontiers in Oncology
- EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
- (2019) Min Wu et al. CANCER LETTERS
- Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
- (2019) Xiaodong Xie et al. Nature Communications
- Tyrosine kinase inhibition of EGFR: a successful history of targeted therapy for NSCLC since 20 years
- (2018) J Vansteenkiste et al. ANNALS OF ONCOLOGY
- Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response
- (2018) Aline G. Souza et al. CURRENT PHARMACEUTICAL DESIGN
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Third generation EGFR TKIs: current data and future directions
- (2018) Chee-Seng Tan et al. Molecular Cancer
- Aptamer-guided nanomedicines for anticancer drug delivery
- (2018) Walhan Alshaer et al. ADVANCED DRUG DELIVERY REVIEWS
- Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress
- (2016) ZHONGLIANG WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives
- (2016) Rui Xue Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Selective turnover of p62/A170/SQSTM1 by autophagy
- (2014) Yoshinobu Ichimura et al. Autophagy
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
- (2013) Yongjie Wei et al. CELL
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
- (2011) Trever G. Bivona et al. NATURE
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
- Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
- (2009) Alessandro Nasti et al. PHARMACEUTICAL RESEARCH
- To Die or Not to Die: That is the Autophagic Question
- (2008) Maria Maiuri et al. CURRENT MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search